Drug application
PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER (PIPERACILLIN SODIUM, TAZOBACTAM SODIUM)
Drugs@FDA NDA 206056 · B BRAUN MEDICAL
Key facts
| Drug name | PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER |
|---|---|
| Active ingredients | PIPERACILLIN SODIUM, TAZOBACTAM SODIUM |
| Application type | NDA |
| Application number | 206056 |
| Company | B BRAUN MEDICAL |
| Dosage forms | POWDER, INTRAVENOUS |
| Strength | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL |
| Marketing status | Prescription |
| Reference listed drug | Yes |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Apr 3, 2025 |
At a glance
- 1–9 Submissions
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: